| INVENTIVA ADR |
| USA |
| Gesundheit |
| US46124U1079 / A2P796 |
| 6IVA (Frankfurt) / IVA (NASDAQ) |
| FRA:6IVA, ETR:6IVA, 6IVA:GR, NASDAQ:IVA |
| - |
| https://inventivapharma.c.. |
|
Inventiva S.A. is a clinical-stage biopharmaceutic..
>Volltext.. |
| 725.52 Mio. EUR |
| 660.6 Mio. EUR |
| 13.66 Mio. EUR |
| -98.09 Mio. EUR |
| -312.12 Mio. EUR |
| -3.77 EUR |
| 57.33 Mio. EUR |
| 122.49 Mio. EUR |
| -91.79 Mio. EUR |
| 2.09 |
| -12.84% |
| -198.57% |
| - |
| - |
| - |
| - |
| INVENTIVA ADR, INVENTIVA |
| 16.12.25 |
|